Effect of Tacrolimus vs Intravenous Cyclophosphamide on Complete or Partial Response in Patients With Lupus Nephritis

Author:

Zheng Zhaohui1,Zhang Haitao2,Peng Xiaomei3,Zhang Chun4,Xing Changying5,Xu Gang6,Fu Ping7,Ni Zhaohui8,Chen Jianghua9,Xu Zhonggao10,Zhao Ming-hui11,Li Shaomei12,Huang Xiangyang13,Miao Lining14,Chen Xiaonong15,Liu Bicheng16,He Yongcheng17,Li Jing18,Liu Lijun19,Kadeerbai Haishan19,Liu Zhangsuo20,Liu Zhihong2

Affiliation:

1. Department of Rheumatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

2. National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China

3. Department of Nephrology, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China

4. Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

5. Department of Nephrology, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, Jiangsu, China

6. Department of Nephrology, Tongji Hospital affiliated with Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

7. Renal Division, Department of Medicine, West China Hospital of Sichuan University, Kidney Research Institute, Chengdu, Sichuan, China

8. Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China

9. Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China

10. Department of Nephrology, The First Hospital of Jilin University, Changchun, Jilin, China

11. Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China, and Peking-Tsinghua Center for Life Sciences, Beijing, China

12. Department of Nephrology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

13. Department of Nephrology, Liuzhou Worker’s Hospital, Liuzhou, Guangxi, China

14. Department of Nephrology, Second Hospital, Jilin University, Changchun, Jilin, China

15. Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

16. Institute of Nephrology, Zhongda Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China

17. Department of Nephrology, Shenzhen Hengsheng Hospital, Shenzhen, Guangdong, China

18. Department of Nephrology, The First Affiliated Hospital of Xinjiang Medical University, Ürümqi, China

19. Astellas Pharma China, Inc.,

20. Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Publisher

American Medical Association (AMA)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3